Many previous studies have shown that high LAMC1 expression promotes tumor progression and can be used as a prognostic biomarker in many cancers, such as hepatocellular carcinoma, colorectal cancer and endometrial cancer [28, 29]. The gene discussed is LAMC1; the disease is hepatocellular carcinoma.